We have audited the accompanying consolidated balance sheets of Unico American Corporation and Subsidiaries (the "Company") as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive loss, changes in stockholders’ equity, and cash flows, for each of the years in the two-year period ended December 31, 2020, and the related notes and Schedules II and III (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.
These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
As of December 31, 2020, unpaid losses and loss adjustment expenses (“loss reserves”), were $74,893,509. As described in Notes 1 and 8 to the consolidated financial statements, loss reserves are management’s best estimate of the ultimate net cost of all reported and unreported losses and loss adjustment expenses incurred, less payments made. There are significant judgments involved in calculating this estimate as well as inherent uncertainties of the ultimate loss settlement cost.
We identified the evaluation of loss reserves as a critical audit matter due to the complexity and subjective judgment required to audit management’s best estimate, which required assessing the selected methods and assumptions, such as paid and incurred loss development factors, used to estimate loss reserves. Specialized actuarial skills, training, and knowledge were needed to evaluate the Company’s actuarial methodologies and the estimate of future claim payment and reporting patterns.
We tested the completeness of the underlying data generated from the Company’s policy administration system by reconciling it to the data used by the Company’s actuary. We tested the accuracy of the data on a sample basis by tracing it to source documents. Furthermore, we engaged an independent actuary with specialized skills, training, and knowledge to assist in assessing management’s methodologies used to estimate loss reserves by comparing it to generally accepted actuarial methods; evaluating management’s estimates by lines of business by performing independent analysis of loss reserves using the Company’s underlying historical claims data; and developing a reserve range based on actuarial methodologies and comparing it to the Company’s total recorded loss reserves.
We have served as the Company’s auditor since 2015.
See accompanying notes to consolidated financial statements.
See accompanying notes to consolidated financial statements.
See accompanying notes to consolidated financial statements.
See accompanying notes to consolidated financial statements.
See accompanying notes to consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2021
NOTE 1 ‑ SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Business
Unico American Corporation (the “Company” or “Unico”) is an insurance holding company that underwrote property and casualty insurance through its insurance company subsidiary; provides property, casualty, and health insurance through its agency subsidiaries; and provided insurance premium financing and membership association services through its other subsidiaries. References to Unico or the Company include both the corporation and its subsidiaries, all of which are wholly owned. Unico was incorporated under the laws of Nevada in 1969.
During the quarter ended September 30, 2021, Unico took actions to cause its subsidiary, Crusader Insurance Company (“Crusader”), to enter into runoff. In connection with its runoff, Crusader began to cease writing new and renewal business and to wind down operations that support the writing of insurance policies. Effective September 30, 2021, Crusader ceased writing any new insurance policies and no longer renews policies after December 8, 2021. Crusader issued notices of non-renewal in accordance with the California Department of Insurance (“CA DOI”) rules and regulations for its existing in-force policies to terminate such policies at the expiration of the current policy periods. In August 2021, Unico also discontinued its premium financing operations formerly conducted through its subsidiary American Acceptance Corporation (“AAC”), which activity is reflected on the Statements of Operations under “Other insurance operations.”
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Unico American Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Basis of Presentation
The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”). As described in Note 14, the Company's insurance subsidiary also files financial statements with regulatory agencies prepared on a statutory basis of accounting that differs from GAAP. Certain reclassifications have been made to prior amounts to conform to the current year’s presentation. The reclassifications had no effect on the Company's previously reported financial condition, results of operations or cash flows.
Going Concern
The Company prepared the accompanying consolidated financial statements on a going concern basis, which assumes that it will realize its assets and satisfy its liabilities in the normal course of business. Unico has a history of recurring losses from operations, and negative cash flows from its operating activities which may continue in the future, and, as a holding company, does not independently generate significant revenue and is dependent on dividends and other cash distributions from Crusader and its other subsidiaries to fund its operations and expenses. Historically, Unico generally received dividends periodically from Crusader, but does not expect to receive any such dividends for the foreseeable future due to prohibitions on dividends imposed by the CA DOI pursuant to the Supervision Agreement (the “Supervision Agreement”), dated as of September 7, 2021, by and between Crusader and the CA DOI and other actions by the CA DOI in its review of the financial statements of Crusader. Crusader’s decreased policyholder surplus caused by additional underwriting losses during 2021, as discussed further in Note 14. Any continued financial support from Crusader will be at the discretion of the Special Examiner appointed pursuant to the Supervision Agreement (the “Special Examiner”). If the Special Examiner does not permit Crusader to continue to provide significant financial support to Unico, Unico will be unable to continue to fund its continued operations and expenses. The Special Examiner has recently informed Crusader that it does not intend to continue to permit Crusader to pay certain expenses attributable to Unico’s status as a public company, including certain legal and accounting expenses without an undertaking by the Company to repay payments made on its behalf by Crusader. The Company will have an account payable to Crusader and Crusader will have an intercompany account receivable due from the Company for such payments made by Crusader and authorized by the Special Examiner. The inability of Crusader to pay certain expenses of the Company will exacerbate Unico’s lack of liquidity. Additionally, many of the potential strategic alternatives that the Unico Board is considering will also depend on continued financial support from Crusader to fund transaction expenses and other costs. If Crusader is not permitted to do so, Unico would be unable to pursue such alternatives, which may otherwise be in the best interests of its stockholders. These circumstances raise substantial doubt about Unico’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and reclassification of assets or the amounts and classifications of liabilities that may result from the outcome of the uncertainty of the Company’s ability to remain a going concern.
Based on Unico’s current cash, and short‑term investments at December 31, 2021, as well as the other factors described herein, there is substantial doubt that Unico will have sufficient cash to meet its operating and other liquidity requirements when they become due during the next twelve months from the date of issuance of the accompanying consolidated financial statements.
Unico needs to improve its consolidated operating results, continue to receive financial support from Crusader, and/or raise substantial additional capital to continue to fund its operations. Unico has taken actions to cause Crusader to enter into runoff and to wind down operations that support the writing of insurance policies. To address its liquidity concerns and meet its capital obligations, Unico has announced a review of strategic alternatives and, with the assistance of a financial advisor, is considering multiple alternatives, including, but not limited to, strategic financing, further scaling back, or eliminating some or all of its remaining business operations, expense reductions, reorganization, merger with another entity, filing for bankruptcy or cessation of operations. There can be no assurances that capital will be available when needed or that, if available, it will be obtained on terms favorable to the Company and its stockholders, particularly in light of the effects that the coronavirus COVID-19 (“COVID-19”) pandemic has had on the capital markets and investor sentiment. In addition, equity or debt financings may have a dilutive effect on the holdings of Unico’s existing stockholders, and debt financings may subject Unico to restrictive covenants, operational restrictions, and security interests in Unico’s assets. Many of these potential alternatives will also depend on continued financial support from Crusader to fund transaction expenses and other costs. If Unico becomes unable to continue as a going concern, Unico may have to dispose of or liquidate its assets and might realize significantly less than the values at which they are carried on its consolidated financial statements. Additionally, Unico may have to write down some or all of its capitalized assets or liquidate some or all of its investments in gross unrealized loss position. These actions may cause Unico’s stockholders to lose all or part of their investment in Unico’s common stock. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Use of Estimates in the Preparation of the Financial Statements
The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these consolidated financial statements relate to losses and loss adjustment expenses. Actual results may differ significantly from the estimates used in preparing the consolidated financial statements.
Supervision Agreement
Crusader and the CA DOI entered into the Supervision Agreement, dated September 7, 2021, at the request of the CA DOI. The Supervision Agreement was requested by the CA DOI because of the CA DOI’s expressed concerns regarding the financial stability of Crusader and the potential effects on Crusader and Crusader’s California policyholders of any potential bankruptcy of Unico. The Supervision Agreement among other things, provides for the appointment by the CA DOI of a Special Examiner to provide supervision and regulatory oversight of Crusader. The Supervision Agreement imposes limitations on Crusader’s ability to take certain actions without the prior written consent of the CA DOI Commissioner (the “Commissioner”), the Special Examiner, or the Special Examiner’s appointed representative. Among the actions that Crusader is prohibited from making without such prior written consent are the following: (i) making payments, engaging in any transaction with or entering into any agreement with, any affiliated or otherwise related person or entity if the cost to Crusader is an individual payment of more than $5,000 or aggregate payments of more than $20,000; (ii) making payments, engaging in any transaction with or entering into any agreement with, any non-affiliated or otherwise unrelated person or entity if the cost to Crusader is an individual payment of more than $5,000 or aggregate payments of more than $20,000; (iii) paying any dividend of any amount; (iv) except as provided in (i) and (ii), making any payments to or on behalf of the Company in connection with any agreement entered into between Crusader and the Company; (v) making any loans to affiliates, officers, directors, stockholders or third parties; (vi) incurring any debt, obligation or liability greater than $5,000; (vii) entering into any new reinsurance contract or treaty or amending any existing reinsurance contract or treaty; (viii) making any material changes in management and essential staffing; (ix) increasing salaries or benefits of officers or directors or making any preferential payment of bonuses or other payments considered legally preferential; and (x) making any other material changes in its normal course of operations, including but not limited to, entering into new lines of business, making major corporate reorganizations, or redomesticating from California. The Supervision Agreement provides that the Special Examiner will meet, which occurred, with Crusader to develop a list of recurring payments under items (i) and (ii) that may not require prior written approval. To date, the Special Examiner has permitted Crusader to provide significant financial support to Unico in the form of reimbursement and/or direct payment of certain operating and other expenses, but there can be no assurance that the Special Examiner will continue to permit Crusader to do so under the Supervision Agreement. If the Special Examiner does not continue to permit Crusader to financially support Unico in the future, Unico will be unable to continue to fund its ongoing operations.
On September 13, 2021, the Special Examiner advised Crusader, through its counsel, that a deficiency existed in certain funds that Unifax is required to maintain, in a fiduciary capacity, for Crusader's benefit. Pursuant to the provisions of California Insurance Code Sections ("CIC") Sections 1733 and 1734, Unifax is required to hold premium payment funds received from policyholders as fiduciary funds in trust maintained for the benefit of Crusader. The Special Examiner informed Crusader that the CA DOI believed that the deficiency in such fiduciary funds was approximately $3,100,000 as of September 13, 2021. As of September 30, 2021, the amount of such deficiency was $2,452,835. In January 2022 Unico, Crusader, and Unifax agreed, with the pre-approval of the Special Examiner, to transfer a computer system, owned by Unico, to Crusader. Unico contributed the computer system at its book value of $1,991,956, to Unifax, and Unifax in turn contributed the computer system to Crusader at its book value of $1,991,956 as a direct reduction in the amount due to Crusader which resulted in a dollar-for-dollar reduction in the premium trust deficiency. The amount of such deficiency was $275,901 as of March 31, 2022, and $432,900 as of May 31, 2022.
Independent Investigation
The Audit Committee of Unico’s Board of Directors retained independent outside counsel, who in turn engaged forensic accountants to work at their direction, to conduct an independent investigation and provide legal advice to the Audit Committee (the “Independent Investigation”), regarding the facts and circumstances relating to, and resulting in, the observed fiduciary funds deficiency. As a result of the Independent Investigation, the Company has determined that, over a period of multiple years, (i) Unifax did not comply with the requirements of the CIC to hold premium trust funds in separate accounts or segregate such funds in accordance with the CIC; (ii) the funds in question were improperly transferred to an operating account of Unifax and were subsequently transferred to a Unico operating account; and (iii) the funds in question were utilized by Unico and its consolidated subsidiaries for general corporate purposes. The Independent Investigation did not find any evidence that any of such funds had been stolen or used for non-corporate purposes.
Investments
The Company’s fixed maturity investments are classified either as held-to-maturity or available-for-sale. Available-for-sale fixed maturity investments and are stated at fair value and held-to-maturity securities are stated at amortized cost. Although part of the Company's investments is classified as available‑for‑sale and the Company may sell investment securities from time to time in response to cash flow requirements, economic, regulatory, and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity, its investment guidelines place primary emphasis on buying and holding high‑quality investments to maturity. Short‑term investments are carried at cost, which approximates fair value. Equity securities are reported at fair value. The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. The unrealized gains or losses from fixed maturities are reported as “Accumulated other comprehensive income (loss),” which is a separate component of stockholders’ equity, net of any deferred tax effect. The net unrealized investment gains on equity securities are reported in the Consolidated Statements of Operations. When a decline in the value of a fixed maturity is considered other-than-temporary, a loss is recognized in the Consolidated Statements of Operations. Realized gains and losses are included in the Consolidated Statements of Operations based on the specific identification method.
The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether it is more likely than not that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes, or the credit quality of the underlying security. If a security meets this criteria, the security's decline in fair value is considered other than temporary and is recorded as a net realized investment loss in the Consolidated Statements of Operations based on the specific identification method. There were no realized investments gains (losses) from other than temporary impairments for any of the periods presented in the accompanying Consolidated Statements of Operations. For each fixed income security that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates the credit loss component of the impairment, if any, from the amount related to all other factors and reports the credit loss component in net realized investment gains (losses).
Short‑term investments include U.S. Treasury bills, certificates of deposit, and commercial paper that are all highly rated and have initial maturities between three and twelve months.
Fair Value of Financial Instruments
The Company employs a fair value hierarchy that prioritizes the inputs for valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs to the valuation techniques. (See Note 5.)
The Company has used the following methods and assumptions in estimating its fair value disclosures for instruments carried at fair value:
| · | Available-for-sale fixed maturity securities, equity securities, and short-term investments – Fair values are obtained from widely accepted third party vendors. |
| · | Cash, cash equivalents, and restricted cash – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. |
| | |
| · | Long-term certificates of deposit – The carrying amounts reported in the Consolidated Balance Sheets for these instruments are at amortized cost which approximates their fair value. |
| | |
| · | Receivables, net – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. |
| | |
| · | Accrued expenses and other liabilities – The carrying amounts reported in the Consolidated Balance Sheets approximate the fair values given the short-term nature of these instruments. |
Property and Equipment
All property and equipment held for use is stated at cost less accumulated depreciation and amortization on the Consolidated Balance Sheets.
Depreciation through the February 12, 2021 sale date on Crusader’s, previously owned building, located at 26050 Mureau Road, Calabasas, California, was computed using the straight-line method over 39 years. Improvements to the building structure were amortized over the useful life of the improvements. Depreciation on furniture, fixtures and equipment in the Calabasas building was computed using the straight-line method over 3 to 15 years. Amortization of tenant improvements in the Calabasas building was being computed using the shorter of the useful life of the tenant improvements or the remaining years of the lease. Refer to Note 6 regarding the sale of the building.
Income Taxes
The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and AAC are allocated taxes or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2018 and California state income tax authorities for tax returns filed starting at taxable year 2017. There are no ongoing examinations of income tax returns by federal or state tax authorities.
As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states that Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes.
The provision for federal income taxes is computed on the basis of income as reported for financial reporting purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Income tax expense provisions increase or decrease in the same period in which a change in tax rates is enacted.
At each balance sheet date, management assesses the need to establish a valuation allowance that reduces deferred tax assets when it is more-likely-than-not that any portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate character within the carryback and carryforward periods available under the tax law. Management considers the reversal of deferred tax liabilities, projected future taxable income of an appropriate nature and tax-planning strategies when making this assessment. In light of the net losses that were generated in recent years, as of December 31, 2021, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $11,939,459 that, in management’s judgment, are not more-likely-than-not to be realized. As of December 31, 2020, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses and other temporary differences in the amount of $10,557,080.
Earnings Per Share
Basic earnings per share exclude the impact of common share equivalents and are based upon the weighted average common shares outstanding. Diluted earnings per share utilize the average market price per share when applying the treasury stock method in determining common share dilution. When outstanding stock options are dilutive, they are treated as common share equivalents for purposes of computing diluted earnings per share and represent the difference between basic and diluted weighted average shares outstanding. In loss periods, the options are excluded from the calculation of diluted earnings per share, as the inclusion of such options would have an anti-dilutive effect.
Revenue Recognition
a. General Agency Operations
Commissions from sales of health insurance are earned and recognized in income based on the satisfaction of a single performance obligation. Marketing, selling, billing, collecting, and administering health insurance policies are a series of distinct services combined as one performance obligation, which is recognized in income monthly over the policy period. Premiums are collected upon the initial sale of health insurance policies and then monthly upon each subsequent periodic payment. As a result, there are limited accounts receivable. Policy fee income is recognized on a pro-rata basis over the terms of the policies.
b. Insurance Company Operation
Premium is earned on a pro‑rata basis over the terms of the policies. Premium applicable to the unexpired terms of policies in force are recorded as unearned premium.
c. Insurance Premium Financing Operations
Premium finance interest may be charged to policyholders who choose to finance insurance premium. Interest is charged at rates that vary with the amount of premium financed. Premium finance interest, if any, is recognized using a method that approximates the interest (actuarial) method. Other charges and fees earned include late fees, returned check fees and payment processing fees that are earned when recorded.
Losses and Loss Adjustment Expenses
The liability for unpaid losses and loss adjustment expenses is based upon the accumulation of individual case estimates for losses reported prior to the close of the accounting period plus estimates based on experience and industry data for development of case estimates and for incurred but unreported losses and loss adjustment expenses.
There is a high level of uncertainty inherent in the evaluation of the required loss and loss adjustment expense reserves for Crusader. The long-tailed nature of liability claims, and the volatility of jury awards exacerbate that uncertainty. Crusader records loss and loss adjustment expense reserves at each balance sheet date based upon management’s best estimate of the ultimate payments that it anticipates will be made to settle all losses incurred and related expenses incurred as of that date for both reported and unreported losses. The ultimate cost of claims is dependent upon future events, the outcomes of which are affected by many factors. Crusader’s claim reserving procedures and settlement philosophy, current and perceived social and economic inflation, current and future court rulings and jury attitudes, improvements in medical technology, and many other economic, scientific, legal, political, and social factors all can have significant effects on the ultimate costs of claims. Changes in Company operations and management philosophy also may cause actual developments to vary from the past. Since the emergence and disposition of claims are subject to uncertainties, the net amounts that will ultimately be paid to settle claims may vary significantly from the estimated amounts provided for in the accompanying consolidated financial statements. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Management believes that the aggregate reserves for losses and loss adjustment expenses are reasonable and adequate to cover the cost of claims, both reported and unreported.
The Company applies judgment in determining estimates for reserves associated with anticipated recoveries of salvage and subrogation on paid losses and loss adjustment expenses based on its historic salvage and subrogation recovery success pattern.
Restricted Funds
Note 1 to the Company’s historical annual audited financial statements (“Note 1”) disclosed a heading titled “Restricted Funds” with a tabular presentation and explanatory footnotes on the Form 10-K for the fiscal year ended December 31, 2020. The Company determined that the Note 1 Disclosure was incorrectly presented in that (i) the amount presented as “Premium Trust Funds” did not reflect the amounts actually held by Unifax as restricted trust funds in the account that was designated in Unico’s records as the “Unifax Premium Trust Account” (the “Premium Trust Account”); (ii) the footnote disclosure to the Note 1 table should have disclosed a deficiency (the “Premium Trust Account Deficiency”) in the amount of funds required to be held in trust by Unifax for the benefit of Crusader; and (iii) the footnote disclosure to the Note 1 table should have disclosed that the funds deposited into the Premium Trust Account were not held in separate accounts or segregated in accordance with the requirements of the California Insurance Code.
Restricted funds are as follows:
| | Year ended December 31 | |
| | 2021 | | | 2020 (Revised) | |
| | | | | | |
| | | | | | |
Premium trust funds (1)(2) | | $ | 381,942 | | | $ | 1,210,243 | |
Assigned to state agencies (3) | | | 500,000 | | | | 998,000 | |
Funds held as collateral (4) | | | 8,162,053 | | | | 787,653 | |
Total restricted funds | | $ | 9,043,995 | | | $ | 2,995,896 | |
(1) | The Company is required by law to segregate from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. As disclosed in further detail in Note 1 above under “Supervision Agreement” and “Independent Investigation,” Unifax did not comply with the requirements of the California Insurance Code to hold such funds in separate accounts or segregate such funds in accordance with the CIC. |
| |
(2) | At December 31, 2020, there was a deficiency (the “Premium Trust Account Deficiency”) in the amount of funds required to be held in trust by Unifax for the benefit of Crusader. The amount of the Premium Trust Account Deficiency was $1,595,135 at December 31, 2020. The amount of the Premium Trust Account Deficiency was $2,172,968 as of December 31, 2021. |
| |
(3) | $300,000 and $798,000 included in fixed maturity investments as of December 31, 2021 and 2020, respectively, and $200,000 included in short-term investments as of December 31, 2021 and 2020, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. |
| |
(4) | Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. |
Deferred Policy Acquisition Costs
Policy acquisition costs consist of commissions, premium taxes, inspection fees, and certain other underwriting costs, which are related to the successful production of Crusader insurance policies. Policy acquisition costs that are eligible for deferral are deferred and amortized as the related premium is earned and are limited to their estimated realizable value based on the related unearned premium plus investment income less anticipated losses and loss adjustment expenses. Ceding commission applicable to the unexpired terms of policies in force is recorded as unearned ceding commission, which is included in deferred policy acquisition costs.
Reinsurance
Crusader employs reinsurance to provide greater diversification of business allowing management to control exposure to potential losses arising from large risks by reinsuring certain levels of risk in various areas of exposure, to reduce the loss that may arise from catastrophes, and to provide additional capacity for growth. Prepaid reinsurance premium and reinsurance receivables are reported as assets and represent ceded unearned premium and reinsurance recoverable on both paid and unpaid losses and loss adjustment expenses, respectively. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured policies. Crusader evaluates each of its ceded reinsurance contracts at its inception to determine if there is sufficient risk transfer to allow the contract to be accounted for as reinsurance under current accounting literature. As of December 31, 2021, and 2020, all such ceded contracts are accounted for as risk transfer reinsurance.
Crusader evaluates and monitors the financial condition of its reinsurers and factors such as collection periods, disputes, applicable coverage defenses and other factors to assess the need for any allowance against anticipated reinsurance recoveries. No such allowance was considered necessary at December 31, 2021 or 2020.
Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows:
| | | | Year ended December 31 | |
Name of Reinsurer | | A.M. Best Rating (1) | | 2021 | | | 2020 | |
| | | | | | | | |
Renaissance Reinsurance U.S. Inc. | | A+ | | $ | 14,339,203 | | | $ | 11,906,416 | |
Hannover Ruck SE | | A+ | | | 13,433,710 | | | | 10,673,173 | |
TOA Reinsurance Company of America | | A | | | 255,521 | | | | 295,188 | |
Other | | A | | | (825 | ) | | | 172 | |
Total | | | | $ | 28,027,609 | | | $ | 22,874,949 | |
(1) | A.M. Best ratings are as of December 31, 2021. |
Concentration of Risks
100% and 99.9% respectively of Crusader’s gross written premium was derived from California during the years ended December 31, 2021 and 2020. In 2021, approximately 26% and 58% of the $732,852 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. In 2020, approximately 30% and 56% of the $727,515 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively.
Stock-Based Compensation
Share-based compensation expense for all share-based payment awards is based on the grant-date fair value estimated in accordance with the provisions of ASC Topic 718, “Compensation - Stock Compensation” using the modified prospective transition method.
Recently adopted standards
In December of 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 removes specific exceptions to the general principles in Topic 740 and improves the financial statement preparer’s application of income tax related guidance. Under previous guidance, an entity may not adjust its annual effective tax rate for any tax law change until the period in which the law is effective. This exception was removed under ASU 2019-12, thereby providing that all effects of a tax law change are recognized in the period of enactment, including adjustment of the estimated annual effective tax rate. The Company adopted ASU 2019-12 effective January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company’s consolidated financial statements.
Standards not yet adopted
In June 2016, the FASB issued Accounting Standards Update No. ASU 2016-13, Measurement of Credit Losses on Financial Instruments, (“ASU 2016-13”). ASU 2016-13 replaces the current incurred loss methodology for recognizing credit losses with a current expected credit loss model, which requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced disclosures for better understanding of significant estimates and judgments used in estimating credit losses. The Company is currently evaluating the effect ASU 2016-13 will have on the Company’s consolidated financial statements but expects the primary changes to be (i) the use of the expected credit loss model for its premium receivables and reinsurance recoverables and (ii) the presentation of credit losses within the available-for-sale fixed maturities portfolio through an allowance method rather than as a direct write-down. ASU 2016-13 will primarily impact the Company’s available-for-sale fixed maturities portfolio and reinsurance recoverables.
In November 2019, the FASB issued Accounting Standards Update No. 2019-10, Financial Instruments – Credit Losses, Derivatives and Hedging, and Leases, (“ASU 2019-10”). ASU 2019-10 updated the effective date for implementing ASU 2016-13 for smaller reporting entities, and that effective date will be for fiscal years beginning after December 15, 2022. Since the Company’s fixed income portfolio is invested primarily in higher rated bonds and the reinsurance is purchased from financially strong reinsurers, the Company believes the adoption of ASU 2016-13 will not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets.
NOTE 2 – CASH, RESTRICTED CASH AND CASH EQUIVALENTS
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets to the amounts shown in the Consolidated Statements of Cash Flows:
| | December 31 | |
| | 2021 | | | 2020 (Revised) | |
| | | | | | |
Cash and Cash Equivalents | | $ | 15,244,709 | | | $ | 2,747,737 | |
Restricted Cash | | | 381,942 | | | | 1,210,243 | |
Total | | $ | 15,626,651 | | | $ | 3,957,980 | |
As of December 31, 2021, and 2020, cash and restricted cash included custodial trust, bank money market accounts, and a bank savings account. Any financial instruments that are readily convertible into known amounts of cash or are so near their maturity that they present an insignificant interest rate risk are considered cash equivalents. Any certificate of deposit which matures in three months or less from the reporting date is considered a cash equivalent.
NOTE 3 – ADVANCE PREMIUM AND PREMIUM DEPOSITS
The insurance company operation records an advance premium liability that represents the deposits on written premium on policies that have been submitted to the Company and are bound, billed, and recorded prior to their effective date of coverage. The advance premium is not included in written premium or in the liability for unearned premium.
Some of the Company’s health and life programs require payments of premium prior to the effective date of coverage; and, accordingly, invoices are sent out as early as two months prior to the coverage effective date. Insurance premium received for coverage months effective after the balance sheet date are recorded as advance premium.
NOTE 4 – INVESTMENTS
A summary of investment income (net of investment expenses), net realized gains, realized gain on real estate sale, and net unrealized investment gains on equity securities is as follows:
| | December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Investment income: | | | | | | |
Fixed maturities | | $ | 1,920,624 | | | $ | 2,068,592 | |
Equity securities | | | 90,596 | | | | 28,727 | |
Short-term investments and cash equivalents | | | 2,660 | | | | 24,603 | |
Gross investment income | | | 2,013,880 | | | | 2,121,922 | |
Less investment expenses | | | (80,887 | ) | | | (133,679 | ) |
Net investment income | | | 1,932,993 | | | | 1,988,243 | |
Net realized investment gains | | | 259,912 | | | | 97,771 | |
Net realized gain on sale of real estate | | | 3,693,858 | | | | - | |
Net unrealized investment gains on equity securities | | | 400,862 | | | | 198,266 | |
Net investment income, realized investment gains, realized gains on real estate sale and unrealized investment gains | | $ | 6,287,625 | | | $ | 2,284,280 | |
The amortized cost, estimated fair value and weighted average yield of fixed maturity investments by contractual maturity are as follows:
Maturities by Year at December 31, 2021 | | Amortized Cost | | | Fair Value | | | Weighted Average Yield | |
| | | | | | | | | |
Due in one year | | $ | 15,758,755 | | | $ | 15,875,423 | | | | 2.21 | % |
Due after one year through five years | | | 19,349,200 | | | | 19,681,599 | | | | 1.80 | % |
Due after five years through ten years | | | 19,335,034 | | | | 19,832,093 | | | | 2.39 | % |
Due after ten years and beyond | | | 17,075,416 | | | | 17,324,290 | | | | 2.35 | % |
Total | | $ | 71,518,405 | | | $ | 72,713,405 | | | | 2.18 | % |
Maturities by Year at December 31, 2020 | | Amortized Cost | | | Fair Value | | | Weighted Average Yield | |
| | | | | | | | | |
Due in one year | | $ | 11,064,202 | | | $ | 11,169,232 | | | | 2.57 | % |
Due after one year through five years | | | 30,090,910 | | | | 31,260,694 | | | | 2.59 | % |
Due after five years through ten years | | | 18,476,051 | | | | 19,806,444 | | | | 2.51 | % |
Due after ten years and beyond | | | 21,238,117 | | | | 21,971,324 | | | | 2.63 | % |
Total | | $ | 80,869,280 | | | $ | 84,207,694 | | | | 2.58 | % |
Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.
The weighted average maturity of the Company’s investments was approximately 6.7 years as of December 31, 2021, and 8.0 years as of December 31, 2020.
The amortized cost and estimated fair values of investments in fixed maturities by category are as follows:
| | Amortized Cost | | | Gross Unrealized Gains | | | Gross Unrealized Losses | | | Estimated Fair Value | |
December 31, 2021 | | | | | | | | | | | | |
Available-for-sale fixed maturities: | | | | | | | | | | | | |
U.S. Treasury securities | | $ | 6,278,764 | | | $ | 67,516 | | | $ | (36,475 | ) | | $ | 6,309,805 | |
Corporate securities | | | 44,370,193 | | | | 1,076,288 | | | | (196,508 | ) | | | 45,249,973 | |
Agency mortgage-backed securities | | | 20,569,448 | | | | 352,466 | | | | (68,287 | ) | | | 20,853,627 | |
Held-to-maturity fixed maturities: | | | | | | | | | | | | | | | | |
Certificates of deposit | | | 300,000 | | | | - | | | | - | | | | 300,000 | |
Total fixed maturities | | $ | 71,518,405 | | | $ | 1,496,270 | | | $ | (301,270 | ) | | $ | 72,713,405 | |
| | | | | | | | | | | | | | | | |
December 31, 2020 | | | | | | | | | | | | | | | | |
Available-for-sale fixed maturities: | | | | | | | | | | | | | | | | |
U.S. Treasury securities | | $ | 10,596,808 | | | $ | 235,373 | | | $ | - | | | $ | 10,832,181 | |
Corporate securities | | | 44,159,926 | | | | 2,347,826 | | | | (55,847 | ) | | | 46,451,905 | |
Agency mortgage-backed securities | | | 25,314,546 | | | | 833,336 | | | | (22,274 | ) | | | 26,125,608 | |
Held-to-maturity fixed maturities: | | | | | | | | | | | | | | | | |
Certificates of deposit | | | 798,000 | | | | - | | | | - | | | | 798,000 | |
Total fixed maturities | | $ | 80,869,280 | | | $ | 3,416,535 | | | $ | (78,121 | ) | | $ | 84,207,694 | |
As of December 31, 2021, six securities were held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of those securities was $8,243,758 and $8,162,053 on December 31, 2021, respectively. As of December 31, 2020, one corporate security, included in available-for-sale fixed maturities, was held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of that security was $824,500 and $787,653 on December 31, 2020, respectively.
A summary of the unrealized gains (losses) on investments carried at fair value and the applicable deferred federal income taxes is as follows:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Gross unrealized gains of fixed maturities | | $ | 1,496,270 | | | $ | 3,416,535 | |
Gross unrealized losses of fixed maturities | | | (301,270 | ) | | | (78,121 | ) |
Net unrealized gains on investments | | | 1,195,000 | | | | 3,338,414 | |
Deferred federal tax expense | | | (250,950 | ) | | | (701,067 | ) |
Net unrealized gains, net of deferred income taxes | | $ | 944,050 | | | $ | 2,637,347 | |
A summary of estimated fair value, gross unrealized losses, and number of securities in a gross unrealized loss position by the length of time in which the securities have continually been in that position is shown below:
| | Less than 12 Months | | | 12 Months or Longer | |
| | Estimated Fair Value | | | Gross Unrealized Losses | | | Number of Securities | | | Estimated Fair Value | | | Gross Unrealized Losses | | | Number of Securities | |
December 31, 2021 | | | | | | | | | | | | | | | | | | |
U.S. Treasury securities | | $ | 481,875 | | | $ | (15,785 | ) | | | 1 | | | $ | 476,016 | | | $ | (20,690 | ) | | | 1 | |
Corporate securities | | | 13,152,240 | | | | (128,502 | ) | | | 15 | | | | 1,179,235 | | | | (68,006 | ) | | | 1 | |
Agency mortgage-backed securities | | | 5,086,187 | | | | (43,019 | ) | | | 8 | | | | 471,479 | | | | (25,268 | ) | | | 1 | |
Total debt securities | | | 18,720,302 | | | | (187,306 | ) | | | 24 | | | | 2,126,730 | | | | (113,964 | ) | | | 3 | |
Equity securities | | | 665,100 | | | | (55,156 | ) | | | 18 | | | | 76,454 | | | | (4,703 | ) | | | 3 | |
Total | | $ | 19,385,402 | | | $ | (242,462 | ) | | | 42 | | | $ | 2,203,184 | | | $ | (118,667 | ) | | | 6 | |
| | Less than 12 Months | | | 12 Months or Longer | |
| | Estimated Fair Value | | | Gross Unrealized Losses | | | Number of Securities | | | Estimated Fair Value | | | Gross Unrealized Losses | | | Number of Securities | |
December 31, 2020 | | | | | | | | | | | | | | | | | | |
U.S. Treasury securities | | $ | - | | | $ | - | | | | - | | | $ | - | | | $ | - | | | | - | |
Corporate securities | | | 2,101,986 | | | | (55,847 | ) | | | 2 | | | | - | | | | - | | | | - | |
Agency mortgage-backed securities | | | 3,223,329 | | | | (22,274 | ) | | | 12 | | | | - | | | | - | | | | - | |
Total debt securities | | | 5,325,315 | | | | (78,121 | ) | | | 14 | | | | - | | | | - | | | | - | |
Equity securities | | | 723,346 | | | | (37,357 | ) | | | 25 | | | | - | | | | - | | | | - | |
Total | | $ | 6,048,661 | | | $ | (115,478 | ) | | | 39 | | | $ | - | | | $ | - | | | | - | |
The Company monitors its investments closely. If an unrealized loss is determined to be other-than-temporary, it is written off as a realized loss through the Consolidated Statements of Operations. The Company’s methodology of assessing other-than-temporary impairments is based on security-specific analysis as of the balance sheet date and considers various factors including the length of time to maturity and the extent to which the fair value has been less than the cost, the financial condition, and the near-term prospects of the issuer, and whether the debtor is current on its contractually obligated interest and principal payments. The unrealized losses as of December 31, 2021, and December 31, 2020, were determined to be temporary.
Although the Company does not intend to sell its fixed maturity investments prior to maturity, the Company may sell investment securities from time to time in response to cash flow requirements, economic, regulatory, and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity. The fixed maturity securities previously held by the Company were sold and called prior to maturity as follows:
| | December 31 | | | December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Fixed maturities securities sold | | | | | | |
Number of securities sold | | | 3 | | | | 15 | |
Amortized cost of sold securities | | $ | 2,194,103 | | | $ | 5,529,470 | |
Realized gains on sales | | $ | 710 | | | $ | 52,053 | |
| | | | | | | | |
Fixed maturities securities called | | | | | | | | |
Number of securities called | | | 10 | | | | 4 | |
Amortized cost of called securities | | $ | 7,167,178 | | | $ | 2,449,503 | |
Realized (losses) gains on calls | | $ | (17,758 | ) | | $ | 497 | |
The unrealized gains or losses from fixed maturities are reported as “Accumulated other comprehensive income or loss,” which is a separate component of stockholders’ equity, net of any deferred tax effect.
The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. A summary of equity securities is shown below:
| | December 31 | | | December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Cost | | $ | 3,532,026 | | | $ | 2,548,440 | |
Unrealized gain | | | 599,127 | | | | 198,266 | |
Fair market value of equity securities | | $ | 4,131,153 | | | $ | 2,746,706 | |
The Company’s investment in fixed maturity securities, held-to-maturity, certificates of deposit included $300,000 and $798,000 of brokered certificates of deposit as of December 31, 2021 and 2020, respectively. All of the Company’s certificates of deposit are within the Federal Deposit Insurance Corporation (“FDIC”) insured permissible limits. Due to the nature of the Company’s business, certain bank accounts may exceed FDIC insured permissible limits.
The following securities from three different banks represent statutory deposits that are assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in the state of Nevada.
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Certificates of deposit | | $ | 300,000 | | | $ | 200,000 | |
Short-term investments | | | 200,000 | | | | 200,000 | |
Total state held deposits | | $ | 500,000 | | | $ | 400,000 | |
All the Company’s brokered and non-brokered certificates of deposit are within the FDIC insured permissible limits. Due to the nature of the Company’s business, certain bank accounts may exceed FDIC insured permissible limits.
Short‑term investments have an initial maturity of one year or less and consist of the following:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Short term bonds | | | 954,750 | | | | - | |
Certificates of deposit | | | 200,000 | | | | 200,000 | |
Total short-term investments | | $ | 1,154,750 | | | $ | 200,000 | |
NOTE 5 – FAIR VALUE OF FINANCIAL INSTRUMENTS
In determining the fair value of its financial instruments, the Company employs a fair value hierarchy that prioritizes the inputs for the valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs for the valuation techniques as follows:
Level 1 – Financial assets and financial liabilities whose values are based on unadjusted quoted prices in active markets for identical assets or liabilities as of the reporting date.
Level 2 – Financial assets and financial liabilities whose values are based on quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in non-active markets; or valuation models whose inputs are observable, directly, or indirectly, for substantially the full term of the asset or liability as of the reporting date.
Level 3 – Financial assets and financial liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the financial assets and financial liabilities as of the reporting date.
The hierarchy gives the highest priority to Level 1 inputs and the lowest priority to Level 3 inputs. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fair value hierarchy level within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Thus, a Level 3 fair value measurement may include inputs that are observable (Level 1 or Level 2) or unobservable (Level 3). The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
The following table presents information about the Company’s financial instruments and their estimated fair values, which are measured on a recurring basis, allocated among the three levels within the fair value hierarchy as of December 31, 2021 and 2020:
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
December 31, 2021 | | | | | | | | | | | | |
Financial instruments: | | | | | | | | | | | | |
Available-for-sale fixed maturities: | | | | | | | | | | | | |
U.S. Treasury securities | | $ | 6,309,805 | | | $ | - | | | $ | - | | | $ | 6,309,805 | |
Corporate securities | | | - | | | | 45,249,973 | | | | - | | | | 45,249,973 | |
Agency mortgage-backed securities | | | - | | | | 20,853,627 | | | | - | | | | 20,853,627 | |
Held-to-maturity securities | | | | | | | | | | | | | | | | |
Certificates of deposits | | | - | | | | 300,000 | | | | - | | | | 300,000 | |
Equity securities | | | 4,131,153 | | | | - | | | | - | | | | 4,131,153 | |
Short-term investments | | | 1,154,750 | | | | - | | | | - | | | | 1,154,750 | |
Total financial instruments at fair value | | $ | 11,595,708 | | | $ | 66,403,600 | | | $ | - | | | $ | 77,999,308 | |
| | | | | | | | | | | | | | | | |
December 31, 2020 | | | | | | | | | | | | | | | | |
Financial instruments: | | | | | | | | | | | | | | | | |
Available-for-sale fixed maturities: | | | | | | | | | | | | | | | | |
U.S. Treasury securities | | $ | 10,832,181 | | | $ | - | | | $ | - | | | $ | 10,832,181 | |
Corporate securities | | | - | | | | 46,451,905 | | | | - | | | | 46,451,905 | |
Agency mortgage-backed securities | | | - | | | | 26,125,608 | | | | - | | | | 26,125,608 | |
Held-to-maturity securities | | | | | | | | | | | | | | | | |
Certificates of deposits | | | - | | | | 798,000 | | | | - | | | | 798,000 | |
Equity securities | | | 2,746,706 | | | | - | | | | - | | | | 2,746,706 | |
Short-term investments | | | 200,000 | | | | - | | | | - | | | | 200,000 | |
Total financial instruments at fair value | | $ | 13,778,887 | | | $ | 73,375,513 | | | $ | - | | | $ | 87,154,400 | |
Fair value measurements are not adjusted for transaction costs. The Company recognizes transfers between levels at either the actual date of the event or a change in circumstances that caused the transfer. The Company did not have any transfers between Levels 1, 2 and 3 of the fair value hierarchy during the years ended December 31, 2021 and 2020.
The spread of the ongoing COVID-19 pandemic and other economic uncertainties which have arisen which are likely to impact the fair value of investments. While the Company does not believe it is exposed to substantial risk from coronavirus-related claims under the insurance policies written by Crusader, it is likely that the fair value of its investment portfolio will be adversely affected by the volatility in the capital market. The financial impact of these uncertainties is unknown at this time.
NOTE 6 – REAL ESTATE HELD FOR SALE, NET AND PROPERTY AND EQUIPMENT, NET
Property and equipment consist of the following:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Real estate held for sale, located in Calabasas, California | | $ | - | | | $ | 10,202,676 | |
Accumulated depreciation and amortization | | | - | | | | (1,867,659 | ) |
Real estate held for sale, net | | $ | - | | | $ | 8,335,017 | |
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Furniture, fixtures, equipment | | | 2,316,885 | | | | 2,191,411 | |
Computer software | | | 466,892 | | | | 467,275 | |
Accumulated depreciation and amortization | | | (2,983,418 | ) | | | (2,423,617 | ) |
Computer software under development | | | 2,354,161 | | | | 1,803,346 | |
Property and equipment, net | | $ | 2,154,520 | | | $ | 2,038,415 | |
On February 12, 2021, the Company, through Crusader, completed the sale of the Company’s headquarters at 26050 Mureau Road, Calabasas, California 91302 (the “Calabasas Building”), for $12,695,000 netting proceeds of $12,028,876 (the “Sale”) to Mureau Road, LLC (“Mureau Road”), a subsidiary of Alliant Capital, Ltd. (“Alliant”). Mureau Road and Alliant do not have any material relationship with the Company or its subsidiaries, other than through the Sale and the Lease (as defined below) transactions. The Company recognized a gain of $3,693,858 on the sale of the Calabasas Building.
On February 12, 2021, the Standard-Multi Tenant Office Lease – Net, dated January 28, 2021 (the “Lease”), by and between Crusader and Mureau Road became effective in connection with the completion of the Sale. The Company has agreed to a lease, which expired on January 31, 2022, with Alliant for the second floor of the Calabasas Building with an initial base rent of approximately $56,963 per month, where the Company will continue to operate its corporate headquarters.
Through the date of the real estate listing, depreciation on the Calabasas Building, owned by Crusader, is computed using the straight-line method over 39 years. Depreciation on furniture, fixtures, and equipment in the Calabasas Building is computed using the straight-line method over 3 to 15 years. Amortization of leasehold improvements in the Calabasas Building is being computed using the shorter of the useful life of the leasehold improvements or the remaining years of the lease. Depreciation and amortization expense on all property and equipment for the years ended December 31, 2021 and 2020 were $569,801 and $673,895, respectively.
For the years ended December 31, 2021 and 2020, the Calabasas Building has generated rental revenue from non-affiliated tenants in the amount of $13,806 and $150,319 and incurred operating expenses in the amount of $235,827 and $677,930, which included depreciation, respectively. These amounts are included in “Other income” from insurance company operations and other operating expenses, respectively, in the Company’s Consolidated Statements of Operations.
The Company capitalizes certain computer software costs purchased from outside vendors for internal use or incurred internally to upgrade the existing systems. These costs also include configuration and customization activities, coding, testing, and installation. Training costs and maintenance are expensed as incurred, while upgrade and enhancements are capitalized if it is probable that such expenditure will result in additional functionality. The capitalized costs are not depreciated until the software is placed into production.
In 2018, the Company determined it needed to upgrade or replace its legacy IT system, which it opted to upgrade because the cost was substantially less. The upgrade was completed in first quarter of 2021 at a cost of approximately $1,500,000, excluding costs of Unico’s employees involved in the upgrade, due to unexpected technical challenges. The Company started depreciating the associated capitalized costs, including the costs of Unico’s employees involved in the upgrade, during the second quarter of 2021.
NOTE 7 – RECEIVABLES, NET
Receivables, net, include premium, commissions and notes receivable and are as follows:
| | December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Premium and commission receivable | | $ | 672,284 | | | $ | 2,476,679 | |
Premium finance notes receivable | | | 755,691 | | | | 2,036,960 | |
Total premium and notes receivable | | | 1,427,975 | | | | 4,513,639 | |
Allowance for doubtful accounts | | | (223,962 | ) | | | (1,192,302 | ) |
Receivables, net | | $ | 1,204,013 | | | $ | 3,321,337 | |
Premium receivable and premium finance notes receivables are substantially secured by unearned premiums and funds held as security for performance. Premium finance notes receivable represents the balance due to AAC, the Company's premium finance subsidiary, from policyholders who elected to finance their premium over a nine-month term. These notes are net of unearned finance charges and credit loss reserves.
Bad debt recoveries were $167,532, related to previously written off balances, and bad debt expense was $6,451 for the years ended December 31, 2021 and 2020, respectively.
NOTE 8 – UNPAID LOSSES AND LOSS ADJUSTMENT EXPENSES
Crusader’s loss and loss adjustment expense case and incurred but not reported (“IBNR”) reserves are as follows:
| | December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Gross reserves: | | | | | | |
Case reserves | | $ | 29,293,117 | | | $ | 26,363,695 | |
IBNR reserves | | | 53,199,557 | | | | 48,529,814 | |
Total gross reserves | | $ | 82,492,674 | | | $ | 74,893,509 | |
| | | | | | | | |
Reserves net of reinsurance: | | | | | | | | |
Case reserves | | $ | 23,057,464 | | | $ | 21,027,703 | |
IBNR reserves | | | 32,319,167 | | | | 31,612,164 | |
Total net reserves | | $ | 55,376,631 | | | $ | 52,639,867 | |
Reserves for losses and loss adjustment expenses before reinsurance for each of Crusader’s lines of business are as follows:
| | Year ended December 31 | |
Line of Business | | 2021 | | | | | | | 2020 | | | | | |
| | | | | | | | | | | | |
CMP | | $ | 81,303,803 | | | | 98.5 | % | | $ | 73,545,181 | | | | 98.2 | % |
Other liability | | | 1,122,823 | | | | 1.4 | % | | | 1,283,174 | | | | 1.7 | % |
Other | | | 66,048 | | | | 0.1 | % | | | 65,154 | | | | 0.1 | % |
Total | | $ | 82,492,674 | | | | 100.0 | % | | $ | 74,893,509 | | | | 100.0 | % |
The Company‘s consolidated financial statements include estimated reserves for unpaid losses and related loss adjustment expenses of the insurance company operation. Crusader sets loss and loss adjustment expense reserves at each balance sheet date based upon management’s best estimate of the ultimate payments that it anticipates will be made to settle all losses incurred and all related loss adjustment expenses incurred as of that date for both reported and unreported claims.
The following table provides an analysis of the roll forward of Crusader’s loss and loss adjustment expense reserves, including a reconciliation of the ending balance sheet liability for the periods indicated:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Reserve for unpaid losses and loss adjustment expenses at beginning of year – net of reinsurance | | $ | 52,639,867 | | | $ | 40,340,625 | |
| | | | | | | | |
Incurred losses and loss adjustment expenses: | | | | | | | | |
Provision for insured events of current year | | | 26,097,435 | | | | 26,683,872 | |
Provision for insured events of prior years | | | (124,595 | ) | | | 7,959,048 | |
Total incurred losses and loss adjustment expenses | | | 25,972,840 | | | | 34,642,920 | |
| | | | | | | | |
Payments: | | | | | | | | |
Losses and loss adjustment expenses attributable to insured events of the current year | | | 8,007,546 | | | | 8,285,021 | |
Losses and loss adjustment expenses attributable to insured events of prior years | | | 15,228,530 | | | | 14,058,657 | |
Total payments | | | 23,236,076 | | | | 22,343,678 | |
| | | | | | | | |
Reserve for unpaid losses and loss adjustment expenses at end of year – net of reinsurance | | | 55,376,631 | | | | 52,639,867 | |
Reinsurance recoverable on unpaid losses and loss adjustment expenses at end of year | | | 27,116,043 | | | | 22,253,642 | |
Reserve for unpaid losses and loss adjustment expenses at end of year per balance sheet, gross of reinsurance | | $ | 82,492,674 | | | $ | 74,893,509 | |
The $124,595 favorable development in 2021 for insured events of prior years for the year ended December 31, 2021, was an improvement compared to the $7,959,048 adverse development of insured events of prior year for the year ended December 31, 2020, due primarily to increases during the year ended December 31, 2020, in 2018 and 2019 accident year IBNR reserves associated with the Apartments & Commercial Buildings and Transportation Business.
The 2020 increases in IBNR were due to higher actuarially developed ultimate incurred losses and loss adjustment expenses primarily as a result of elevated expected claims severity.
At each review period, actual claims costs that emerge are compared with the claims costs that were expected to emerge during that development period. Sometimes the previous claims costs estimate prove to have been too high; sometimes they prove to have been too low. The fluctuation in development of insured events of prior years’ underscores the inherent uncertainty in insurance claims costs. Management reviews claims costs that appear to be different from the historical claims costs to determine whether those differences are a normal part of the process or an indication that a change in reserve assumptions is appropriate. Management concluded that the differences noted above are differences between actual and expected claims costs that emerge from time to time, particularly in an insurer the size of Crusader.
The following table presents loss development information by accident year, including cumulative incurred and paid losses and allocated loss adjustment expenses (“ALAE”), net of reinsurance, as well as cumulative claim frequency and the total of incurred but not reported liabilities plus expected development on reported claims as of December 31, 2021:
Accident Year | | Cumulative Incurred | | | Cumulative Paid | | | Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims | | | Cumulative Number of Reported Claims | |
| | | | | | | | | | | | |
2012 | | | 18,353,966 | | | | 18,355,881 | | | | - | | | | 967 | |
2013 | | | 22,852,457 | | | | 22,849,314 | | | | (2 | ) | | | 850 | |
2014 | | | 17,965,556 | | | | 17,817,189 | | | | (108,710 | ) | | | 760 | |
2015 | | | 25,332,806 | | | | 23,197,570 | | | | (525,502 | ) | | | 749 | |
2016 | | | 27,006,706 | | | | 24,528,218 | | | | (1,584,393 | ) | | | 808 | |
2017 | | | 26,103,135 | | | | 21,188,239 | | | | (2,301,034 | ) | | | 825 | |
2018 | | | 19,179,716 | | | | 13,750,695 | | | | (3,465,021 | ) | | | 614 | |
2019 | | | 18,723,515 | | | | 10,898,586 | | | | (5,558,880 | ) | | | 648 | |
2020 | | | 22,611,110 | | | | 9,769,654 | | | | (6,518,530 | ) | | | 771 | |
2021 | | | 23,198,334 | | | | 5,027,785 | | | | (11,452,987 | ) | | | 626 | |
Total | | $ | 221,327,301 | | | $ | 167,383,131 | | | $ | (31,515,059 | ) | | | | |
The following table reconciles the above cumulative incurred and paid data to Crusader’s loss and loss adjustment expense reserves:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Cumulative incurred losses and ALAE | | $ | 221,327,301 | | | $ | 218,410,701 | |
Less cumulative paid losses and ALAE | | | (167,383,131 | ) | | | (167,214,395 | ) |
| | | | | | | | |
Reserve for unpaid losses and ALAE (latest 10 accident years) | | | 53,944,170 | | | | 51,196,306 | |
Reserves for unpaid losses and ALAE (beyond latest 10 accident years) | | | 68,604 | | | | 79,703 | |
Reserves for unpaid unallocated loss adjustment expenses | | | 1,363,857 | | | | 1,363,858 | |
| | | | | | | | |
Reserve for unpaid losses and loss adjustment expenses, net of reinsurance | | | 55,376,631 | | | | 52,639,867 | |
Reinsurance recoverable on unpaid losses and loss adjustment expenses | | | 27,116,043 | | | | 22,253,642 | |
Reserve for unpaid losses and loss adjustment expenses, gross of reinsurance | | $ | 82,492,674 | | | $ | 74,893,509 | |
Crusader’s liability for unpaid loss and loss adjustment expense reserves consists of case reserves and reserves for IBNR claims. Case reserves are established by claims personnel based on a review of the facts known at the time the claim is reported and are subsequently revised as more information about a claim becomes known. IBNR is estimated using various actuarial methods and techniques and includes (1) reserves for losses and loss adjustment expenses on claims that have occurred but for which claims have not yet been reported to Crusader, and (2) a provision for expected future development on case reserves for information not currently known.
At the end of each fiscal quarter, Crusader’s reserves for each accident year (i.e., for all claims occurring within each year) are re-evaluated independently by the Company’s president, the Company’s chief financial officer, and an independent consulting actuary. Generally accepted actuarial methods, including the widely used Bornhuetter-Ferguson and loss development methods, are employed to estimate ultimate claims costs. An actuarial central estimate of the ultimate claims’ costs and IBNR reserves is ultimately determined by management and tested for reasonableness by the independent consulting actuary.
The Company determines the number of reported claims based on the number of loss events. A claim is considered a single loss event, per policy, and it may include multiple claimants and multiple coverages on a single policy. The cumulative number of reported claims is a sum of open claims, closed claims, and claims closed without payment.
NOTE 9 – DEFERRED POLICY ACQUISITION COSTS
The following table provides an analysis of the roll forward of the Company’s deferred policy acquisition costs:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Deferred policy acquisition costs at beginning of year | | $ | 3,503,248 | | | $ | 3,619,594 | |
Policy acquisition costs deferred during year | | | 2,926,203 | | | | 4,782,461 | |
Policy acquisition costs amortized during year | | | (5,442,645 | ) | | | (4,898,807 | ) |
Deferred policy acquisition costs at end of year | | $ | 986,806 | | | $ | 3,503,248 | |
Deferred policy acquisition costs consist of commissions (net of ceding commission), premium taxes, inspection fees, and certain other underwriting costs, which are related to and vary with the production of Crusader policies. Policy acquisition costs are deferred and amortized as the related premium is earned. Deferred acquisition costs are reviewed to determine if they are recoverable from future income on insurance policies generated from these costs, including investment income. The Company recognized an allowance against its deferred acquisition costs of $1,409,654 and $0 for the years ended December 31, 2021 and 2020, respectively.
NOTE 10 – ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities consist of the following:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Premium payable | | $ | 508,147 | | | $ | 393,466 | |
Unearned policy fee income | | | 224,536 | | | | 454,883 | |
Retirement plans | | | 12,413 | | | | 145,473 | |
Accrued salaries and employee benefits | | | 53,449 | | | | 973,504 | |
Commission payable | | | (251 | ) | | | 869 | |
Security deposit for Calabasas Building sale | | | - | | | | 380,850 | |
Other | | | 1,467,943 | | | | 1,228,405 | |
Total accrued expenses and other liabilities | | $ | 2,266,237 | | | $ | 3,577,450 | |
NOTE 11 – COMMITMENTS AND CONTINGENCIES
The Company, by virtue of the nature of the business conducted by it, becomes involved in numerous legal proceedings as either plaintiff or defendant. From time to time, the Company is required to resort to legal proceedings against vendors providing services to the Company or against customers or their agents to enforce collection of premiums, commissions, or fees. These routine items of litigation do not materially affect the Company and are handled on a routine basis by the Company through its counsel.
Crusader is also subject to regulatory and governmental examinations, requests for information, inquiries, investigations, and threatened legal actions and proceedings by state regulators and others. Crusader receives numerous requests, orders for documents, and information in connection with various aspects of its regulated activities. Regulatory and governmental requests for information, inquires, certain examinations and investigations are routinely handled by Crusader. Crusader may involve outside counsel in regulatory matters depending on the nature of the matter.
The Company establishes reserves for lawsuits, regulatory actions, and other contingencies for which the Company is able to estimate its potential exposure and believes a loss is probable. For loss contingencies believed to be reasonably possible, the Company discloses the nature of the loss contingency, an estimate of the possible loss, a range of loss, or a statement that such an estimate cannot be made.
Likewise, the Company is sometimes named as a cross‑defendant in litigation, which is principally directed against an insured who was issued a policy of insurance directly or indirectly through Crusader. Incidental actions related to disputes concerning the issuance or non‑issuance of individual policies are sometimes brought by customers or others. These items are also handled on a routine basis by counsel, and they do not generally affect the operations of the Company. Management is confident that the ultimate outcome of pending litigation should not have an adverse effect on the Company’s consolidated results of operations or financial position. The Company vigorously defends itself unless a reasonable settlement appears appropriate.
Crusader has received a number of coronavirus-related business interruption claims. With the exception of one claim for which the investigation is still ongoing, all such claims were denied after the individual circumstances of each claim were reviewed to determine whether insurance coverage applied. Like many companies in the property casualty insurance industry, Crusader was named as defendant in lawsuits seeking insurance coverage under the policies issued by Crusader for alleged economic losses resulting from the shutdown or suspension of their businesses due to COVID-19. Although the allegations vary, the plaintiffs generally seek a declaration of insurance coverage, damages for breach of contract in unspecified amounts for claim denials, interest, and attorney fees. Some of the lawsuits also allege that the insurance claims were denied in bad faith or otherwise in violation of state laws and seek extra-contractual or punitive damages.
Crusader denies the allegations in these lawsuits and intends to continue to vigorously defend them. Although the policy terms vary in general, the claims at issue in these lawsuits were denied because the policyholder identified had no direct physical loss, such as fire or water damage, to property at the insured premises, and the governmental orders that led to the complete or partial shutdown of the business were not due to the existence of any direct physical loss or damage to property in the immediate vicinity of the insured premises and did not prohibit access to the insured premises, as required by the terms of the insurance policies. Depending on the individual policy, additional policy terms and conditions may also prohibit coverage, such as exclusions for pollutants, ordinance or law, loss of use, and acts or decisions. Most of Crusader’s policies also contain an exclusion for losses caused directly or indirectly by “virus or bacteria.”
In addition to the inherent difficulty in predicting litigation outcomes, COVID-19 business income coverage lawsuits present a number of uncertainties and contingencies that are not yet known, including how many policyholders will ultimately file claims, the number of lawsuits that will be filed, the extent to which any class may be certified, and the size and scope of any such classes. The legal theories advanced by plaintiffs vary by case. These lawsuits are in the early stages of litigation; many complaints continue to be amended; several have been dismissed voluntarily and may be refiled; and others have been dismissed by trial courts. Some early decisions on motion filings have been appealed.
On March 23, 2021, ten policyholders sued Crusader in a putative class action entitled Anchors & Whales LLC et al. v. Crusader Insurance Company, Superior Court of the State of California for the County of San Francisco (CGC-21-590999). The action alleged that Crusader wrongly denied claims for business interruption coverage made by bars and restaurants related to COVID-19 and related government orders that limited or halted operations of bars and restaurants. The action further alleged that Crusader acted unreasonably in denying the claims, and it sought as damages the amounts allegedly due as contract benefits under the insurance policies, attorneys’ fees and costs, punitive damages, and other unspecified damages. The lawsuit alleged a putative class of all bars and restaurants in California that were insured by Crusader for loss of business income, who made such a claim as a result of “one or more Governmental Orders and the presence of the COVID-19 virus on the property,” and whose claim was denied by Crusader. On October 1, 2021, Crusader was granted its motions on the pleadings without leave to amend and the lawsuit was dismissed. On December 15, 2021. Anchors & Whales LLC filed a notice of appeal with California Court of Appeals, 1st Appellate District, Division 2 (A164412). The opening brief of Anchors & Whales LLC is due to be filed by August 12, 2022. The Company cannot predict the actions of the Court of Appeals.
Crusader has received seven claims related to civil unrest through July 11, 2022. One claim remains open for potential subrogation. The losses and loss adjustment expenses associated with those claims will not exceed Crusader’s $500,000 excess of loss reinsurance treaty retention.
On May 9, 2022, Donald Esparza filed an action in the Superior Court of California, County of Los Angeles, against the Company, Michael Budnitsky and Steven L. Shea (22VECV00627) relating to the termination of the employment of Mr. Esparza by the Company. The action is entitled Donald Esparza v. Unico American Corporation, Michael Budnitsky and Steven Shea ( The action alleges that the Company (i) failed to timely pay wages upon termination of employment in violation of the California Labor Code (ii) failure to provide accurate itemized wage statements in violation of the California Labor Code (iii) violated the California unfair competition law by the forgoing alleged violations of the California Labor Code; and (iv) failure to provide the personnel file of Mr. Esparza after written demand in violation of the California Labor Code. The action seeks general and statutory damages, including without limitation lost wages, back pay, front pay, and lost earning capacity; special damages, statutory penalties and other relief, including reasonable attorneys’ fees. The employment of Mr. Esparza, a former officer, director and employee of Crusader, was terminated in connection with a reduction in force of employees in connection with the runoff of Crusader. Defendant Budnitsky is a former officer of the Company and Crusader. Defendant Shea is the current Chairman of the Board, President and Chief Executive Officer of the Company and Crusader. The Company cannot predict the eventual outcome of the Esparza litigation, whether there will be an ultimate resolution, or any eventual loss, fines or penalties related to the action. It is the intent of the Company to vigorously defend the action brought against it by Mr. Esparza.
NOTE 12 – REINSURANCE
A reinsurance transaction occurs when an insurance company transfers (cedes) a portion of its exposure on policies written to a reinsurer that assumes that risk for a premium (ceded premium). Reinsurance does not legally discharge Crusader from primary liability under its policies. If the reinsurer fails to meet its obligations, Crusader must nonetheless pay its policy obligations. Crusader’s primary excess of loss reinsurance agreements, or treaties, during the years ended December 31, 2021 and 2020, with Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE which are both A+ rated. Crusader’s retention on losses is $500,0000 under these contracts. Reinsurance treaties are generally structured in layers, with different negotiated economic terms and retention of participation, or liability, in each layer.
The effect of reinsurance on written premium, earned premium, and incurred losses and loss adjustment expenses is as follows:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
Written premium: | | | | | | |
Direct | | $ | 32,871,625 | | | $ | 36,338,800 | |
Assumed | | | 3,395,010 | | | | 304,030 | |
Ceded | | | (11,551,580 | ) | | | (8,078,748 | ) |
Net written premium | | $ | 24,715,055 | | | $ | 28,564,082 | |
| | | | | | | | |
Earned premium: | | | | | | | | |
Direct | | $ | 38,278,730 | | | $ | 36,108,230 | |
Assumed | | | 1,844,931 | | | | 156,639 | |
Ceded | | | (11,693,756 | ) | | | (8,096,701 | ) |
Net earned premium | | $ | 28,429,905 | | | $ | 28,168,168 | |
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
Incurred losses and loss adjustment expenses: | | | | | | |
Direct | | $ | 35,218,127 | | | $ | 48,971,172 | |
Assumed | | | 836,622 | | | | 89,204 | |
Ceded | | | (10,081,909 | ) | | | (14,417,456 | ) |
Net incurred losses and loss adjustment expenses | | $ | 25,972,840 | | | $ | 34,642,920 | |
Ceded earned premium as a percentage of gross earned premium (direct and assumed earned premium) was 29% in 2021 and 22% in 2020.
Crusader’s primary excess of loss reinsurance agreements during the years ended December 31, 2021 and 2020 are as follows:
Loss Year | | Reinsurers | | A.M. Best Rating | | Retention | |
| | | | | | | |
2021 | | Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE | | A+ A+ | | $ | 500,000 | |
2020 | | Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE | | A+ A+ | | $ | 500,000 | |
Crusader’s primary excess of loss reinsurance agreements, or treaties, during the years ended December 31, 2021 and 2020, are with Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE, both A+ rated. In calendar years 2021 and 2020, Crusader retained a participation in its excess of loss reinsurance treaties of 0% in its 1st layer (reinsured losses between $500,000 and $1,000,000), 0% in its 2nd layer (reinsured losses between $1,000,000 and $4,000,000), and 0% in its clash layer (reinsured losses between $4,000,000 and $8,000,000). Crusader’s retention on losses is $500,000 under these contracts.
Crusader also has catastrophe (“CAT”) reinsurance treaties from various highly rated California authorized and California unauthorized reinsurance companies. These reinsurance treaties help protect Crusader against losses in excess of certain retentions from catastrophic events that may occur on property risks which Crusader insures. In calendar years 2021 and 2020, Crusader retained a participation in its catastrophe excess of loss reinsurance treaties of 5% in its 1st layer (reinsured losses between $1,000,000 and $10,000,000) and 0% in its 2nd layer (reinsured losses between $10,000,000 and $46,000,000). Crusader’s retention on losses is $1,000,000 under these contracts. In 2022 the catastrophe excess of loss reinsurance treaties was reduced to $16,000,000 with 0% participation and a $1,000,000 retention. Also, Crusader has not had a single CAT claim since 1992.
Crusader also has facultative reinsurance treaties from a highly rated California authorized reinsurance company. Unlike the excess of loss treaties which cover all risks underwritten by Crusader, the facultative reinsurance treaties cover specific risks for properties with total insured values in excess of $4,000,000, (the property coverage limit of the excess of loss treaties). In calendar year 2020 and during the first five months of 2021, the facultative reinsurance treaties provided coverage for reinsured losses between $4,000,000 and $8,000,000. From June 2021, the facultative reinsurance treaties had two sections which provide coverage for reinsured losses between $4,000,000 and $9,000,000 (Section A) and $4,000,000 and $15,000,000 (Section B) depending on location of the insured risk
On April 1, 2020, Crusader and Unifax entered into a reinsurance arrangement with USIC), pursuant to which USIC would underwrite property and casualty insurance policies by and through Unifax and such policies would be reinsured by Crusader. On September 2, 2020, the Company placed a moratorium on placing any new risks with USIC by Unifax pending negotiations among Crusader, Unifax, and USIC pursuant to the issues raised by the DOI regarding the structure of the reinsurance arrangement and its compliance with the California Insurance Holding Company System Act (the “Insurance Act”).
On November 24, 2020, as a result of such negotiations with the DOI, Crusader, Unifax and USIC agreed to rescind certain agreements by and among USIC, Crusader and Unifax. The effect of such rescissions was that the rescinded agreements were deemed never to have existed and no insurance policies were deemed issued, and no premium deemed written, collected or reported with respect to those agreements. Further, on November 24, 2020, the parties entered into various restructured arrangements in order to address the issues raised by the DOI with respect to California insurance laws. In particular, the parties eliminated all intercompany duties so that the arrangement would not require prior approval by the DOI under the Insurance Act. Details of the restructured arrangements with USIC include the following:
| · | On November 24, 2020, USIC and Crusader entered into a new Quota Share Reinsurance Agreement, effective April 1, 2020, (the “New Reinsurance Agreement”), pursuant to which Crusader will reinsure all of USIC’s liability for policies issued by USIC and produced by Unifax for property, general liability, CMP property, CMP liability and other miscellaneous coverages, subject to certain maximum policy limits. Policies placed with USIC by Unifax and reinsured with Crusader prior to November 24, 2020 remain in place without interruption or change and are subject to the New Reinsurance Agreement. |
| | |
| · | On November 24, 2020, USIC and Unifax entered into a Surplus Line Broker Agreement, effective April 1, 2020 (the “Broker Agreement”), pursuant to which, and subject to the terms, conditions and limitations set forth therein, USIC authorized Unifax to act as its broker and agent for the purpose of producing and administering certain specified classes of insurance policies, which are the subject of the New Reinsurance Agreement. Under the Broker Agreement, Unifax is entitled to retain a commission for policies produced based on a percentage of the premiums on business placed with USIC. Unifax has agreed to indemnify and hold USIC harmless from any losses relating to the Broker Agreement. The Broker Agreement may be terminated in specified events, including by any party upon 90 days written notice to the other parties and automatically upon cancellation or termination of the New Reinsurance Agreement. |
| | |
| · | On November 24, 2020, USIC and U.S. Risk Managers, Inc. (“U.S. Risk”), a subsidiary of the Company, entered into a Claims Administration Agreement, effective as of April 1, 2020 (the “Claims Administration Agreement”). Pursuant to the Claims Administration Agreement, USIC appointed U.S. Risk, which is a licensed claims adjuster in the state of California, to adjust and settle claims on its behalf in connection with the surplus lines policies issued by USIC in connection with the New Reinsurance Agreement. U.S. Risk will be paid a fee by Unifax on behalf of USIC based on a percentage of earned premium. U.S. Risk will establish an account for payment of claims by U.S. Risk (the “Loss Fund Account”) pursuant to the Claims Administration Agreement. Pursuant to the terms of the New Reinsurance Agreement, Crusader will fund the Loss Fund Account provided for in the Claims Administration Agreement on behalf of USIC.U.S. Risk has agreed to indemnify and hold USIC harmless from any losses relating to the Claims Administration Agreement. The Claims Administration Agreement may be terminated in specified events, including by any party upon 90 days written notice to the other parties and automatically upon cancellation or termination of the Broker Agreement. |
Termination of Reinsurance Arrangement
On August 31, 2021, Crusader and United Insurance Company ("USIC"), terminated the Quota Share Reinsurance Agreement ( the "Reinsurance Agreement") effective April 1, 2020, by and between Crusader and USIC. Pursuant to the Reinsurance Agreement, Crusader agreed to reinsure all of USIC's liability for policies issued by USIC and produced by Unifax, for property, general liability, commercial multiple peril ("CMP"), liability and other miscellaneous coverages, subject to certain maximum policy limits. Crusader's obligations under the Reinsurance Agreement continue after termination but issued after termination for business in force at the time of termination, for policies with effective dates prior to the termination but issued after the termination date, and for policies that must be issued or renewed as a matter of law until the expiration of the policies.
On August 31, 2021, as result of the termination of the Reinsurance Agreement, the Surplus Line Broker Agreement (the "broker Agreement") effective April 1, 2020, by and between Unifax and USIC, automatically terminated. pursuant to the Broker agreement, USIC authorized Unifax to act as its broker for the purpose of producing and administering certain specified classes of insurance policies, which are the subject of the Reinsurance Agreement. Unifax's obligations under the Broker Agreement continue after termination for insurance business reinsured under the Broker Agreement. Unifax's obligations including handling and servicing of all policies until their expiration.
On August 31, 2021, as a result of the termination of the Broker Agreement, the Claims Administration Agreement (the " Claims Administration Agreement"), effective April 1, 2020, by and between U.S. Risk and USIC, automatically terminated. pursuant to the Claims Administration Agreement, USIC appointed U.S. risk to adjust and settle claims on its behalf in connection with the surplus lines policies issued by USIC in connection with the Reinsurance Agreement. Upon termination of the Claims Administration Agreement, U.S. Risk is obligated (unless revoked by USIC) to continue to manage claims during the runoff of the business reinsured.
The Reinsurance Agreement was mutually terminated by Crusader and USIC. There were no early termination penalties incurred as a result of the termination. The Reinsurance Agreement provides for a minimum ceding fee, and, upon termination of the Reinsurance Agreement, the minimum ceding fee was pro-rated to the date of termination unless there were policies issued after the termination of the Reinsurance Agreement. In such case, the minimum ceding fee will continue past the termination of the Reinsurance Agreement until such time as no further policies are issued. USIC waived any additional ceding fees payable under the Reinsurance Agreement under the agreement to terminate that agreement.
Under the Reinsurance Agreement, Crusader was required to secure its obligations to USIC for unearned premium reserves, if any, and loss reserves (losses incurred and not reported and loss reported but unpaid) in a security fund, trust agreement or letter of credit to permit USIC to receive credit for the reinsurance ceded to Crusader by USIC. Such security was required because crusader is not authorized to transact insurance in Delaware the domiciliary state of USIC. Initially, the security required to be provided by Crusader was 150% of the unearned premium and loss reserves. USIC was permitted to request additional security for the unearned premium and loss reserves in the event (i) the A.M. Best rating Crusader is at any time reduced; or (ii) the A.M. Best rating of Crusader is at any time removed or withdrawn; or (iii) there is a reduction the capital and policyholder surplus of Crusader by 10% or more in any rolling 12-month period or (iv) Crusader fails to maintain its Cat excess of loss reinsurance coverage at certain levels. As of December 31, 2021, six securities were held as collateral with Comerica, pursuant to the reinsurance trust agreement among crusader, USIC and Comerica to secure payment of Crusader's liabilities and performance of its obligation under the reinsurance with USIC. The estimated fair value and amortized cost of those securities was $8,243,758 and $8,162,053 on December 31, 2021, respectively. The estimated aggregate fair value and amortized cost of these securities was $7,944,916 and $7,836,756, on March 31, 2022, respectively. As of April 30, 2022, the estimated market value decreased to $7,663,701. Such market values are used in the trust fund calculation by USIC . The increase in the security request is a result of a decline in the market value of the securities and an increase in the collateral from 150% to 325% because of Crusade's loss of the AM best rating and the decline in policyholder surplus. If Crusader fails to provide the additional security requested by USIC, USIC may draw down the full amount of the funds in the reinsurance trust agreement. Crusader is reviewing the request of USIC and believes that the asserted loss reserves used in their calculation may be incorrect. Any increase to the reinsurance trust agreement by Crusader will require the consent of the Special examiner. Any drawdown of the reinsurance of the reinsurance trust agreement by USIC may have a materially adverse effect on the financial condition of Unico. As of December 31, 2020, one corporate security, included in available-for-sale fixed maturities, was held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of that security was $824,500 and $787,653 on December 31, 2020, respectively.
Crusader has no reinsurance recoverable balances in dispute.
NOTE 13 – PROFIT SHARING PLAN
The Unico American Corporation Profit Sharing Plan (“Plan”) covers Company’s employees who are at least 21 years of age and have met certain service and eligibility requirements. Unico American Corporation is the Plan sponsor and the Plan administrator. Fidelity Management Trust Company is the Plan trustee. The Plan is intended to be a qualified retirement plan under the Internal Revenue Code. Under the Plan, participants have the option to elect to make 401(k) and Roth 401(k) deferral contributions that are matched at up to 4%. Under the Plan, participants have the option to elect to make 401(k) and Roth 401(k) deferral contributions which are not matched by the Company. In addition, pursuant to the terms of the Plan, the Company may contribute to participants an amount determined by the Board of Directors. Beginning in 2023 the Company decided that it will not make this optional contribution. Participants must be employed by the Company on the last day of the Plan year to be eligible for a contribution. Participants are eligible to request a distribution of their account balance upon death, retirement, minimum required distributions, and termination of employment. The Company modified the Plan so that all the participants immediately vested in their plan at December 31, 2021.
Contributions to the Plan are as follows:
Year ended December 31, 2021 | | $ | 171,205 | |
Year ended December 31, 2020 | | $ | 154,331 | |
NOTE 14 – STATUTORY CAPITAL AND SURPLUS
Crusader is required to file statutory financial statements with insurance regulatory authorities prepared on an accounting basis prescribed or permitted by such authorities. Statutory accounting practices differ in certain respects from GAAP. The more significant of the differences for statutory accounting practices are (a) policy acquisition and commission costs are expensed when incurred rather than over the periods covered by the policies; (b) fixed maturity securities are reported at amortized cost, or the lower of amortized cost or fair value, depending on the quality of the security as specified by the National Association of Insurance Commissioners (“NAIC”); (c) non-admitted assets are charged directly against surplus; (d) loss and loss adjustment expense reserves and unearned premium reserves are stated net of reinsurance; (e) federal income taxes are recorded when payable and deferred taxes, subject to limitations, are recognized but only to the extent that they do not exceed a specified percentage of statutory surplus; and (f) changes in deferred taxes are recorded directly to surplus as regards policyholders. Additionally, the cash flow presentation is not consistent with GAAP and reconciliation from net income to cash provided by operations is not presented. Comprehensive income is not presented under statutory accounting practices.
Crusader’s statutory capital and surplus are as follows:
As of December 31, 2021 | | $ | 22,494,454 | |
As of December 31, 2020 | | $ | 26,893,515 | |
Crusader’s statutory net loss is as follows:
Year ended December 31, 2021 | | $ | (1,774,020 | ) |
Year ended December 31, 2020 | | $ | (12,862,588 | ) |
The (“CA DOI”) conducts periodic financial examinations of Crusader. The last exam was performed in 2017. The Company has complied with all comments and recommendations identified in the report of examination, and none of the issues in that report of examination had any material effect on Crusader.
Crusader is restricted in the amount of dividends it may pay to its parent in any 12-month period without prior approval of the CA DOI. Generally, without prior regulatory approval, insurance companies may pay a dividend in any 12-month period up to the greater of (a) 10% of its statutory surplus or (b) its statutory net income for the preceding calendar year. Reference is made to Note 1 regarding the Supervision Agreement with CA DOI that requires CA DOI approval of all dividends effective September 7, 2021. The CA DOI advised in April 2021, the Crusader was prohibited from paying dividends during the 2021 and for the years 2022 through 2025. During the years ended December 31, 2021 and 2020, Crusader issued cash dividends of $0 and $4,000,000 to Unico, respectively.
On December 31, 2021 and December 31, 2020, Crusader's RBC Level was less than 300% of its Authorized Control Level RBC, and its statutory accounting basis combined ratio was in excess of 120% for the year then ended. The RBC Level when coupled with statutory accounting basis combined ratio triggered Company Action Events under the RBC for the years then ended. On March 24, 2021 Crusader submitted to the CA DOI a comprehensive Risk Based Capital Plan (the "RBC Plan") to increase the adjusted capital above 300% and to address the actions that Crusader would take to correct the conditions that resulted in the Company Action Level Event. On July 2, 2021, the Company submitted a revised RBC Plan, which addressed issues raised by the CA DOI ( the " 2021 Revised RBC Plan") No action was taken by the CA DOI regarding the 2021 revised RBC Plan. As of December 31, 2021 a second Company Action Event occurred. At December 31, 2021, Crusader's RBC Level was less than 300%, with a combined ratio greater than 130%, which resulted in another Company Action Level event (the “2022 Company Action Level Event”). As a result of the 2022 Company Action Level Event, Crusader was required to submit another comprehensive Risk Based Capital Plan (“2022 RBC Plan”) to the CA DOI. Crusader submitted its 2022 RBC Plan on May 15, 2022. On June 9, 2022, the CA DOI requested additional information regarding the 2022 RBC Plan, which information is to be submitted by July 24, 2022. The CA DOI may accept Crusader’s 2022 RBC Plan to correct the conditions that lead to the 2022 Company Action Event, or it may request that a revised plan be submitted, or it may take no action with respect to the 2022 RBC Plan.. After the Plans are submitted, the CA DOI may request additional changes to the revised RBC Plan to address various corrective actions that Crusader and/or the Company will take, including, without limitation, increasing the capital of Crusader. Depending on the scope and nature of any such requests from the CA DOI, regarding the 2022 RBC Plan the Company and Crusader may not be able to implement certain corrective actions, including the potential infusion of capital to Crusader. The Company continues to be engaged in discussions with the CA DOI on various strategic alternatives to address the RBC issues.
NOTE 15 – STOCK PLANS
The Company’s 2021 Equity Incentive Plan (the "Equity Incentive Plan") covers 500,000 shares of Unico's common stock (subject to adjustment in the case of merger, consolidation, reorganization, recapitalization, stock split, reverse stock split, split up, spin-off, combination of shares, exchange of shares, stock dividend, dividend in kind, etc.) and was approved by Unico’s stockholders on May 27, 2021. The Equity Incentive Plan provides for the grant of the following equity-based incentive awards to participants: (i) non-qualified stock options, (ii) stock appreciation rights, (iii) restricted stock, (iv) restricted stock units and (v) other stock-based awards. Through the date of this filing, there have been 44,250 non-qualified stock options granted, 30,000 were forfeited and 14,250 outstanding. and 48,000 restricted stock grants, 31,000 forfeited with 17,000 outstanding under the Equity Incentive Plan, of which none were vested and exercisable.
The exercise price, term, and other conditions applicable to each non-qualified stock option and restricted stock granted under the Equity Incentive Plan are determined by the Company’s Compensation Committee of the Board of Directors. The exercise price of the stock options is set on the grant date and may not be less than the fair market value per share of the Company’s stock on that date (at market close). The non-qualified stock options granted under the Plan in 2021 vest 25% on the first anniversary of the grant date and 25% annually thereafter on the anniversary date and expire four years after the date of the grant. The restricted stock grants granted under the Plan in 2021 vest 100% on the fourth anniversary of the grant date.
The Company recognized stock-based compensation expense in the amount of $11,589 for all awards issued under the Equity Incentive Plan in the “Salaries and employee benefits” line item in the Consolidated Statements of Operations for the year ended December 31, 2021.
The fair value of each option award is estimated on the date of the grant using the Black-Scholes Option-Pricing Model using a number of complex and subjective variables. These variables include expected stock price volatility over the term of the awards, a risk-free interest rate and expected dividends.
Expected dividend yield is based on the historical dividend behavior as well as the expected dividend behavior of the Company. Expected volatility is based on the historical volatility of the Company’s stock. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve for a 30-day treasury in effect at the time of grant. The expected term represents an estimate of time the options are expected to remain outstanding. In accordance with ASC Topic 718, “Compensation – Stock Compensation,” the Company estimates forfeitures at the time of the grant and revises those estimates in subsequent periods if the actual forfeitures differ from those estimates.
The assumptions used to value each option award granted during the year ended December 31, 2021, are as follows:
Weighted-average grant date fair value | | $ | 4.52 | |
Expected dividend yield | | | 0.00 | % |
Expected volatility | | | 96.35 | % |
Risk-free interest rate | | | 0.09 | % |
Expected term (years) | | | 4.00 | |
Expected forfeiture | | | 50.00 | % |
The following table summarizes non-qualified stock option and restricted stock grants activity for the year ended December 31, 2021:
| | Number of Shares | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Terms | | | Aggregate Intrinsic Value | |
| | | | | | | | | | | | |
Outstanding at December 31, 2020 | | | - | | | | - | | | | - | | | | - | |
Non-qualified stock option granted | | | 14,250 | | | $ | 4.52 | | | | 4.00 | | | | - | |
Restricted stock granted | | | 17,000 | | | | 4.52 | | | | 4.00 | | | | - | |
Forfeited or expired | | | (61,000 | ) | | | 4.52 | | | | - | | | | - | |
Exercised | | | - | | | | - | | | | - | | | | - | |
Outstanding at December 31, 2021 | | | 31,250 | | | $ | 4.52 | | | | 3.79 | | | | - | |
Exercisable at December 31, 2021 | | | - | | | | - | | | | - | | | | - | |
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price and the exercise price, multiplied by the number of in the money options) that would have been received by the option holders had all options been exercised on December 31, 2021.
Options were granted to employees during 2021. Unrecognized compensation cost was $152,003 as of December 31, 2021 and is expected to be recognized over a weighted-average exercise period of 3.74 years. As of December 31, 2021, 500,000 shares of the Company’s common stock were available under the Equity Incentive Plan.
NOTE 16 – TAXES ON INCOME
The provision for taxes on income consists of the following:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
Federal expense | | | | | | |
Deferred | | | 450,117 | | | | 3,566,840 | |
Total tax expense | | $ | 450,117 | | | $ | 3,566,840 | |
| | | | | | | | |
State expense | | | | | | | | |
Current | | $ | 8,800 | | | $ | 8,800 | |
Deferred | | | - | | | | (28,042 | ) |
Total tax expense (benefit) | | $ | 8,800 | | | $ | (19,242 | ) |
| | | | | | | | |
Total expense | | | | | | | | |
Current | | $ | 8,800 | | | $ | 8,800 | |
Deferred | | | 450,117 | | | | 3,538,798 | |
Total tax expense | | $ | 458,917 | | | $ | 3,547,598 | |
The income tax provision reflected in the Consolidated Statements of Operations is different than the expected federal income tax rate of 21% on income as shown in the following table:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Computed income tax benefit at 21% | | $ | (1,095,010 | ) | | $ | (3,768,138 | ) |
Tax effect of: | | | | | | | | |
State tax expense (benefit), net of federal tax benefit | | | 137,312 | | | | (572,511 | ) |
Change in valuation allowance – state net operating losses | | | (130,360 | ) | | | 557,310 | |
Change in valuation allowance – federal | | | 1,547,392 | | | | 7,319,959 | |
Other, including nondeductible expenses | | | 3,620 | | | | 10,920 | |
Other – prior year true up | | | (4,037 | ) | | | 58 | |
Income tax expense | | $ | 458,917 | | | $ | 3,547,598 | |
Significant components of the Company’s net deferred tax assets and liabilities are as follows:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
Deferred tax assets: | | | | | | |
Discount on loss reserves | | $ | 605,164 | | | $ | 531,845 | |
Unearned premium | | | 599,571 | | | | 759,659 | |
Unearned commission income | | | - | | | | 438,574 | |
Unearned policy fee income | | | 62,834 | | | | 127,293 | |
Net operating loss carryforwards | | | 8,584,487 | | | | 7,769,603 | |
State net operating loss carryforwards | | | 2,509,115 | | | | 2,402,438 | |
Unrealized losses on investments | | | - | | | | - | |
Bad debt reserve | | | 62,673 | | | | 333,649 | |
Other | | | 474,854 | | | | 237,803 | |
Total gross deferred tax assets | | | 12,898,698 | | | | 12,600,864 | |
Less valuation allowance | | | 11,939,459 | | | | 10,557,080 | |
Total deferred tax assets | | $ | 959,239 | | | $ | 2,043,784 | |
| | | | | | | | |
Deferred tax liabilities: | | | | | | | | |
Policy acquisition costs | | $ | 191,586 | | | $ | 858,705 | |
State tax on undistributed insurance company earnings | | | 25,357 | | | | 84,219 | |
Federal tax liability on state deferred tax assets | | | 63,456 | | | | 91,277 | |
Depreciation and amortization | | | 302,073 | | | | 266,880 | |
Unrealized gains on investments | | | 376,767 | | | | 742,703 | |
Total deferred tax liabilities | | $ | 959,239 | | | $ | 2,043,784 | |
| | | | | | | | |
Net deferred tax assets | | $ | - | | | $ | - | |
The Company recognizes deferred tax assets and liabilities for the future tax consequences related to differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases, and for tax credits. The Company evaluates its deferred tax assets for recoverability based on available evidence, including assumptions about future profitability, reversal patterns of recorded deferred tax assets and deferred tax liabilities, and capital gain generation. Some or all of the Company’s deferred tax assets could expire unused if the Company is unable to generate taxable income of a sufficient nature in the future to utilize them.
If the Company determines it is more-likely-than-not that it would not be able to realize all or a portion of its deferred tax assets in the future, the Company will reduce the deferred tax asset through a charge to earnings in the period in which the determination is made. This charge could have a materially adverse effect on the Company’s results of operations and financial condition. In addition, the assumptions used to make this determination are subject to change from period to period based on changes in tax laws or variances between the Company’s projected operating performance and actual results. As a result, management’s judgment is required in assessing the possible need for a deferred tax asset valuation allowance.
As of December 31, 2021, the Company had deferred tax assets of 8,584,487 generated from 40,878,510 of federal net operating loss carryforwards that will begin to expire in 2035 and deferred tax assets of $2,509,115 generated from state net operating loss carryforwards which begin to expire in 2028. In connection with preparation of its consolidated financial statements, the Company periodically performs an analysis of future income projections to determine the adequacy of the valuation allowance. In light of the net losses that were generated in recent years, for the years ended December 31, 2021 and December 31, 2020, the Company has established a full valuation allowance against all deferred tax assets in the amount of $11,939,459 and $10,557,080, respectively.
The current federal effected state tax rate is 6.98%.
The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and AAC are allocated taxes, or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2018 and California state income tax authorities for tax returns filed starting at taxable year 2017. There are no ongoing examinations of income tax returns by federal or state tax authorities.
As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states where Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes.
As of December 31, 2021, the Company had no unrecognized tax benefits, no unrecognized additional liabilities or reduction in deferred tax asset, and no uncertain tax positions. In addition, the Company had not accrued interest and penalties related to unrecognized tax benefits. However, if interest and penalties would need to be accrued related to unrecognized tax benefits, such amounts would be recognized as a component of federal income tax expense.
NOTE 17 – REPURCHASE OF COMMON STOCK – EFFECT ON STOCKHOLDERS’ EQUITY
On August 10, 2020, the Board authorized a share repurchase program (the “2020 Program”) for up to $5,000,000 of the currently outstanding shares of the Company’s common stock. The 2020 Program was effective immediately and replaced the Company’s existing share repurchase program that was adopted by the Board on December 19, 2008 (the “2008 Program”) to acquire from time to time up to an aggregate of 500,000 shares of the Company’s common stock. The purchases under the 2020 Program may be made from time to time in the open market, through block trades, 10b5-1 trading plans, privately negotiated transactions or otherwise and in accordance with applicable laws, rules and regulations. The timing and actual number of the shares repurchased under the 2020 Program will depend on a variety of factors including price, market conditions and corporate and regulatory requirements. The Company intends to fund the share repurchases under the 2020 Program from cash on hand. The 2020 Program does not commit the Company to repurchase shares of its common stock and it may be amended, suspended or discontinued at any time. The Company repurchased its shares under the 2020 Program and 2008 Program in unsolicited transactions as follows:
| | December 31 | | | December 31 | |
| | 2021 | | | 2020 | |
| | | | | | |
2020 Program | | | | | | |
Number of shares repurchased | | | 22 | | | | 857 | |
Cost of shares repurchased | | | | | | | | |
Allocated to retained earnings | | $ | 91 | | | $ | 4,071 | |
Allocated to capital | | | 10 | | | | 422 | |
Total cost of shares repurchased | | $ | 101 | | | $ | 4,493 | |
| | | | | | | | |
2008 Program | | | | | | | | |
Number of shares repurchased | | | - | | | | 978 | |
Cost of shares repurchased | | | | | | | | |
Allocated to retained earnings | | | - | | | $ | 5,760 | |
Allocated to capital | | | - | | | | 480 | |
Total cost of shares repurchased | | $ | - | | | $ | 6,240 | |
The Company has remaining authority under the 2020 Program to repurchase up to $4,995,406 of the currently outstanding shares of the Company’s common stock as of December 31, 2020. The Company has retired or will retire all stock repurchased under the 2020 Program and 2008 Program. Effective January 2022, the Company suspended the 2020 Program and ceased any further repurchases of its shares from stockholders from the Company.
NOTE 18 – RELATED PARTY TRANSACTIONS
Altonji Consulting, LLC, owned by Gerard Altonji, a member of the Company’s Board of Directors, was engaged to provide consulting services for a $20,000 fee of which $15,000 was paid during the year ended December 31, 2020.
NOTE 19 – LOSS PER SHARE
A reconciliation of the numerator and denominator used in the basic and diluted loss per share calculation is presented as follows:
| | Year ended December 31 | |
| | 2021 | | | 2020 | |
Basic Loss Per Share | | | | | | |
Net loss numerator | | $ | (5,673,251 | ) | | $ | (21,491,113 | ) |
| | | | | | | | |
Weighted average shares outstanding denominator | | | 5,304,872 | | | | 5,305,829 | |
| | | | | | | | |
Per share amount | | $ | (1.07 | ) | | $ | (4.05 | ) |
| | | | | | | | |
Diluted Loss Per Share | | | | | | | | |
Net loss numerator | | $ | (5,673,251 | ) | | $ | (21,491,113 | ) |
| | | | | | | | |
Weighted average shares outstanding | | | 5,304,872 | | | | 5,305,829 | |
Effect of diluted securities | | | - | | | | - | |
Diluted shares outstanding denominator | | | 5,304,872 | | | | 5,305,829 | |
| | | | | | | | |
Per share amount | | $ | (1.07 | ) | | $ | (4.05 | ) |
As of December 31, 2021, and 2020, the Company had no common share equivalents that were excluded in the diluted loss per share calculation for years ended December 31, 2021 and 2020.
NOTE 20 – ACCUMULATED OTHER COMPREHENSIVE INCOME
The table below details the components of accumulated other comprehensive income at year end:
| | Pre-Tax Amount | | | Tax (Expense) Benefit | | | Net-of-Tax Amount | |
December 31, 2020 | | $ | 3,338,414 | | | $ | (701,067 | ) | | $ | 2,637,347 | |
Changes in unrealized loss on available-for-sale securities | | | (2,025,511 | ) | | | 425,357 | | | $ | (1,600,154 | ) |
Reclassification adjustment for gains included in net loss | | | (117,903 | ) | | | 24,760 | | | $ | (93,143 | ) |
December 31, 2021 | | $ | 1,195,000 | | | $ | (250,950 | ) | | $ | 944,050 | |
December 31, 2019 | | $ | 1,497,299 | | | $ | (314,433 | ) | | $ | 1,182,866 | |
Changes in net unrealized gain on investments | | | 1,905,367 | | | | (400,127 | ) | | $ | 1,505,240 | |
Reclassification adjustment for net realized gains included in net loss | | | (642,524 | ) | | | 13,493 | | | $ | (50,760 | ) |
December 31, 2020 | | $ | 3,338,413 | | | $ | (701,067 | ) | | $ | 2,637,347 | |
NOTE 21 – SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued. Except as disclosed below and elsewhere, no events have occurred subsequent to December 31, 2021 requiring disclosure or recording in the consolidated financial statements.
New Lease
On January 11, 2022, Crusader entered into a sublease agreement (the “New Lease”) with Western General Insurance Company, in Liquidation, a California corporation (“Western General”) for the lease of approximately 4,199 rentable square feet of office space located at 5230 Las Virgenes Road, Suite 100, Calabasas, CA 91302 (the “Premises”). The New Lease is subject and subordinate to that certain Office Lease by and between Western General and Colorado Capital Calabasas LLC, a Delaware limited liability Company, dated August 1, 2021. Crusader intends to use the Premises for its new corporate headquarters.
The term of the New Lease commenced on February 1, 2022 (the “Commencement Date”) and will terminate on January 31, 2023, unless earlier terminated pursuant to the terms of the Lease.
Beginning on the Commencement Date, Crusader is obligated to make monthly rent payments in an amount of $10,539. In addition, Crusader is obligated to pay Western General its proportionate share, 5.45%, of operating expenses. Crusader was also required to deliver to Western General an initial payment of $20,539, $10,000 of which is held by Western General as a refundable security deposit.
Further outsourcing of Claims Processing
In January 2022 Crusader engaged a third-party administrator (“TPA”) outside of the Unico Group of Companies to assist in the claim’s adjudication and settlement process. This outside TPA will supplement U.S. Risk as the company is in runoff and is expected increased claims activity will be outsourced to the TPA through the remainder of 2022. The Crusader staff adjust claims and oversees all outside claim services such as attorneys, independent or outside claim adjusters, investigators, and experts, as necessary. Engagement of this TPA should allow for increased control over paid allocated loss adjustment expenses and reduction the open claims inventory. The financial impact of engaging the TPA cannot be reasonably estimated at this time
Further Significant Reduction in Premium Trust Account Deficiency with Unifax
In January 2022 Unico, Crusader, and Unifax agreed, with the pre-approval of the Special Examiner, to transfer a computer system, owned by Unico, to Crusader. Unico contributed the computer system at its book value of $1,991,956 to Unifax, and Unifax in turn contributed the computer system to Crusader at its book value of $1,991,956 as a direct reduction in the amount due to Crusader which resulted in a dollar-for-dollar reduction in the premium deficiency. The amount of such deficiency was $275,901 as of March 31, 2022, and $432,900 as of May 31, 2022.
NOTE 22 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)
Summarized unaudited quarterly financial data for each of the calendar years 2021 and 2020 is as follows:
| | Comparable Period by Quarter Ended | |
| | March 31 | | | June 30 | | | September 30 | | | December 31 | |
Calendar Year 2021 | | | | | | | | | | | | |
Total revenues | | $ | 11,471,654 | | | $ | 8,132,605 | | | $ | 8,595,648 | | | $ | 8,188,477 | |
Income (loss) before taxes | | $ | 2,542,339 | | | $ | (1,430,835 | ) | | $ | (2,450,619 | ) | | $ | (3,875,219 | ) |
Net income (loss) | | $ | 2,267,703 | | | $ | (1,406,811 | ) | | $ | (2,510,198 | ) | | $ | (4,023,945 | ) |
Income (loss) per share: Basic and Diluted | | $ | 0.43 | | | $ | (0.27 | ) | | $ | (0.47 | ) | | $ | (0.76 | ) |
| | | | | | | | | | | | | | | | |
Calendar Year 2020 | | | | | | | | | | | | | | | | |
Total revenues | | $ | 8,005,181 | | | $ | 7,976,227 | | | $ | 8,259,686 | | | $ | 8,319,017 | |
Loss before taxes | | $ | (1,145,498 | ) | | $ | (384,562 | ) | | $ | (14,345,916 | ) | | $ | (2,067,539 | ) |
Net loss | | $ | (1,043,826 | ) | | $ | (434,814 | ) | | $ | (17,940,488 | ) | | $ | (2,071,985 | ) |
Loss per share: Basic and Diluted | | $ | (0.20 | ) | | $ | (0.08 | ) | | $ | (3.38 | ) | | $ | (0.39 | ) |
NOTE 22 – SUPPLEMENTARY INFORMATION ON LOSS AND ALAE DEVELOPMENT (UNAUDITED)
The following table presents cumulative incurred losses and ALAE, net of reinsurance, for years ended December 31:
Accident | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year | | 2012 (1) | | | 2013 (1) | | | 2014 (1) | | | 2015 (1) | | | 2016 (1) | | | 2017 (1) | | | 2018 (1) | | | 2019 (1) | | | 2020 (1) | | | 2021 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2012 | | $ | 18,511,598 | | | | 19,532,022 | | | | 18,895,666 | | | | 18,344,175 | | | | 18,050,131 | | | | 17,914,837 | | | | 18,235,335 | | | | 18,355,031 | | | | 18,327,346 | | | | 18,353,966 | |
2013 | | | | | | $ | 19,570,946 | | | | 20,118,343 | | | | 20,323,841 | | | | 21,742,580 | | | | 22,798,398 | | | | 22,397,394 | | | | 22,859,132 | | | | 22,802,931 | | | | 22,852,457 | |
2014 | | | | | | | | | | $ | 16,884,731 | | | | 15,394,995 | | | | 14,930,960 | | | | 17,640,211 | | | | 18,034,749 | | | | 17,898,306 | | | | 18,048,285 | | | | 17,965,556 | |
2015 | | | | | | | | | | | | | | $ | 20,452,199 | | | | 20,840,034 | | | | 22,471,512 | | | | 21,707,615 | | | | 23,006,844 | | | | 24,495,614 | | | | 25,332,806 | |
2016 | | | | | | | | | | | | | | | | | | $ | 21,646,663 | | | | 22,908,016 | | | | 24,126,775 | | | | 25,677,378 | | | | 26,337,621 | | | | 27,006,706 | |
2017 | | | | | | | | | | | | | | | | | | | | | | $ | 21,914,736 | | | | 23,453,130 | | | | 23,876,588 | | | | 25,091,934 | | | | 26,103,135 | |
2018 | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 19,048,233 | | | | 18,099,500 | | | | 20,670,880 | | | | 19,179,716 | |
2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 17,349,941 | | | | 19,182,851 | | | | 18,723,515 | |
2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 24,302,958 | | | | 22,611,110 | |
2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 23,198,334 | |
(1) | The information for the years 2012 through 2020 is presented as unaudited required supplementary information. |
The following table presents cumulative paid losses and ALAE, net of reinsurance, for years ended December 31:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year | | 2012 (1) | | | 2013 (1) | | | 2014 (1) | | | 2015 (1) | | | 2016 (1) | | | 2017 (1) | | | 2018 (1) | | | 2019 (1) | | | 2020 (1) | | | 2021(1) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2012 | | $ | 6,719,982 | | | $ | 11,673,621 | | | | 13,411,125 | | | | 15,369,629 | | | | 16,734,967 | | | | 17,265,513 | | | | 17,638,646 | | | | 18,001,581 | | | | 18,020,565 | | | | 18,355,881 | |
2013 | | | | | | $ | 7,594,731 | | | | 10,656,777 | | | | 14,319,057 | | | | 19,067,334 | | | | 21,415,490 | | | | 21,875,978 | | | | 22,364,215 | | | | 22,802,275 | | | | 22,849,314 | |
2014 | | | | | | | | | | $ | 3,826,263 | | | | 6,082,893 | | | | 9,173,947 | | | | 14,556,687 | | | | 16,843,128 | | | | 17,487,722 | | | | 17,806,537 | | | | 17,817,189 | |
2015 | | | | | | | | | | | | | | $ | 6,263,796 | | | | 11,151,955 | | | | 14,978,639 | | | | 17,700,688 | | | | 20,148,880 | | | | 21,502,400 | | | | 23,197,570 | |
2016 | | | | | | | | | | | | | | | | | | $ | 7,435,120 | | | | 12,009,273 | | | | 15,916,432 | | | | 21,438,785 | | | | 23,326,143 | | | | 24,528,218 | |
2017 | | | | | | | | | | | | | | | | | | | | | | $ | 6,405,641 | | | | 11,503,228 | | | | 15,289,400 | | | | 18,869,369 | | | | 21,188,239 | |
2018 | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 4,959,689 | | | | 9,254,754 | | | | 12,129,118 | | | | 13,750,695 | |
2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 4,292,275 | | | | 7,603,418 | | | | 10,898,586 | |
2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 6,004,292 | | | | 9,769,654 | |
2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 5,027,785 | |
(1) | The information for the years 2012 through 2020 is presented as unaudited required supplementary information. |
The following table presents average annual percentage payout of incurred claims by age, net of reinsurance as of December 31, 2021:
Years | | | 1 | | | | 2 | | | | 3 | | | | 4 | | | | 5 | | | | 6 | | | | 7 | | | | 8 | | | | 9 | | | | 10 | |
| | | 27.5 | % | | | 17.8 | % | | | 16.1 | % | | | 16.2 | % | | | 9.0 | % | | | 4.1 | % | | | 2.1 | % | | | 0.8 | % | | | 0.3 | % | | | 0.3 | % |
The percentages in the above table do not add up to 100% because the percentages represent averages across all accident years at each development stage.